 | • レポートコード：MRC2304I0177 • 出版社/出版日：Persistence Market Research / 2023年1月26日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界の鼻アレルギー治療市場について調査・分析を行い、市場の現状と今後の展望を整理しています。本書は、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症危機分析、需要分析・予測、治療別（免疫治療、抗ヒスタミン剤、脱血栓剤、コルチコステロイド、その他）分析、疾患別（季節性鼻炎、通年性鼻炎、職業性鼻炎）分析、投与経路別（経口、鼻腔、眼内、静脈）分析、流通チャネル別（小売薬局、病院薬局、Eコマース）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、Merck & Co.、Boehringer Ingelheim、AstraZeneca、GlaxoSmithKline PLC、Sanofi S.A.、Johnson & Johnson、Teva Pharmaceutical Industries Ltd.、Alcon (Novartis AG)、Stallergenes Greer、Allergy Therapeutics、ALK-Abelló A/S、Hanmi Pharmaceutical、Immunotek、Regeneron Pharmaceuticals、Abdi Ibrahim Pharmaceuticals、Glenmarkなどの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症危機分析 ・需要分析・予測 ・世界の鼻アレルギー治療市場規模：治療別 - 免疫治療の市場規模 - 抗ヒスタミン剤の市場規模 - 脱血栓剤の市場規模 - コルチコステロイドの市場規模 - その他医療の市場規模 ・世界の鼻アレルギー治療市場規模：疾患別 - 季節性鼻炎における市場規模 - 通年性鼻炎における市場規模 - 職業性鼻炎における市場規模 ・世界の鼻アレルギー治療市場規模：投与経路別 - 経口における市場規模 - 鼻腔における市場規模 - 眼内における市場規模 - 静脈投与における市場規模 ・世界の鼻アレルギー治療市場規模：地域別 - 北米の鼻アレルギー治療市場規模 - 中南米の鼻アレルギー治療市場規模 - ヨーロッパの鼻アレルギー治療市場規模 - 東アジアの鼻アレルギー治療市場規模 - 南アジアの鼻アレルギー治療市場規模 - オセアニアの鼻アレルギー治療市場規模 - 中東・アフリカの鼻アレルギー治療市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Nasal Allergy Treatment Market – Report Scope
A recent market study published by Persistence Market Research on the nasal allergy treatment market offers a global industry analysis for 2017-2022 and an opportunity assessment for 2022-2032. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the nasal allergy treatment market, growth prospects of the market are obtained with maximum precision.
The report features unique and salient factors that may make a huge impact on the development of the nasal allergy treatment market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.
The report provides detailed information about the current and future growth prospects of the nasal allergy treatment market in the most comprehensive way for a better understanding of readers.
Key Market Segments
This study on the nasal allergy treatment market offers information divided into five important segments – treatment, disease, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Treatment
Immunotherapy
Antihistamines
Decongestants
Corticosteroids
Others
Disease
Seasonal Allergic Rhinitis
Perennial Allergic Rhinitis
Occupational Allergic Rhinitis
Distribution Channel
Retail Pharmacies
Hospital Pharmacies
e-Commerce
Route of Administration
Oral
Nasal
Intraocular
Intravenous
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa
Chapter 1 – Executive Summary
The report commences with the executive summary of the nasal allergy treatment market report, which includes a summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the nasal allergy treatment market as well as the key trends influencing the market.
Chapter 2 – Market Overview
Readers can find detailed taxonomy and treatment definition/scope /limitations and inclusions and exclusions of the nasal allergy treatment market in this chapter, which helps the readers to understand basic information about the nasal allergy treatment market.
Chapter 3 – Key Market Trends
This section highlights the key trends influencing the nasal allergy treatment market, which will help readers in understanding the current trends and their impact on market growth.
Chapter 4 – Key Success Factors
This section highlights the market context impacting the nasal allergy treatment market, which will help readers in understanding promotional strategies, by key manufacturers, key regulations, reimbursement scenario, pipeline analysis, value chain analysis, PESTEL analysis, and Porter’s analysis that are expected to create a positive impact on the growth of the nasal allergy treatment market during the forecast period.
Chapter 5– Market Background
This chapter explains the key macroeconomic factors that are expected to influence the growth of the nasal allergy treatment market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the nasal allergy treatment market, which include the drivers, restraints, and opportunity analysis.
Chapter 6 – COVID-19 Crisis Analysis
This section provides the current and expected impact of COVID-19 on the nasal allergy treatment market.
Chapter 7– Global Nasal Allergy Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032
This section explains the global market value or size analysis and forecasts for the nasal allergy treatment market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2022), and an incremental $ opportunity for the forecast period (2022–2032).
Chapter 8– Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022-2032, by Treatment
Based on treatment, the nasal allergy treatment market is segmented into immunotherapy, antihistamines, decongestants, corticosteroids, and others. In this chapter, readers can find information about a detailed analysis of the market by different treatments available in the nasal allergy treatment market and their growth over the forecast period.
Chapter 9– Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Disease
Based on disease, the nasal allergy treatment market is segmented into seasonal allergic rhinitis, perennial allergic rhinitis, and occupational allergic rhinitis. In this chapter, readers can find information about a detailed analysis of the market by diseases available in the nasal allergy treatment market and their growth over the forecast period.
Chapter 10– Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration
Based on the route of administration, the nasal allergy treatment market is segmented into oral, nasal, intraocular, and intravenous. In this chapter, readers can find information about a detailed analysis of the market by various routes of administration available in the nasal allergy treatment market and their growth over the forecast period.
Chapter 11– Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Based on distribution channels, the nasal allergy treatment market is segmented into retail pharmacies, hospital pharmacies, and e-commerce. In this chapter, readers can find information about a detailed analysis of the market by distribution channels available in the nasal allergy treatment market and their growth over the forecast period.
Chapter 12 – Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022-2032, by Region
This chapter explains how the nasal allergy treatment market will grow across seven geographic regions, North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa (MEA).
Chapter 13– North America Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the North American nasal allergy treatment market along with a country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on treatment, distribution channel, route of administration, disease, and country of the nasal allergy treatment market in the North American region.
Chapter 14– Latin America Nasal Allergy Treatment market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes the growth prospects of the nasal allergy treatment market in leading countries such as Brazil, Mexico, Argentina, and the rest of Latin America. Readers can find thorough information about the growth parameters based on treatment, distribution channel, route of administration, disease, and country in the Latin America nasal allergy treatment market during 2022-2032.
Chapter 15– Europe Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes the growth prospects of the nasal allergy treatment market based on the development of the new product, regulatory approvals, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and the Rest of Europe are included in this chapter.
Chapter 16– East Asia Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022-2032
China, Japan, and South Korea are the prime subjects of assessment to obtain the growth prospects of the East Asia nasal allergy treatment market. In addition, in this chapter, readers can find thorough information about the growth parameters of the East Asia nasal allergy treatment market through 2032.
Chapter 17– South Asia Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022-2032
India, Thailand, Indonesia, Malaysia, and the rest of South Asia are the prime subjects of assessment to obtain the growth prospects of the nasal allergy treatment market. In addition, in this chapter, readers can find thorough information about the growth parameters of the South Asia nasal allergy treatment market growth over the forecast period.
Chapter 18– Oceania Nasal Allergy Treatment market Analysis 2017-2021 and Forecast 2022-2032
This chapter consists of important parameters that have a huge impact on the growth of the nasal allergy treatment market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania nasal allergy treatment market.
Chapter 19– Middle East and Africa Nasal Allergy Treatment market Analysis 2017-2021 and Forecast 2022-2032
This chapter provides information on how the nasal allergy treatment market will grow in the major countries in the MEA region, such as GCC Countries, Turkey, and the rest of MEA during 2022-2032.
Chapter 20– Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key players operating in the nasal allergy treatment market.
Chapter 21– Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the nasal allergy treatment market including company overview, revenue shares, strategic overview, and recent company developments. Some of the major market players featured in the report are Merck & Co., Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline PLC, Sanofi S.A., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Alcon (Novartis AG), Stallergenes Greer, Allergy Therapeutics, ALK-Abelló A/S, Hanmi Pharmaceutical, Immunotek, Regeneron Pharmaceuticals, Abdi Ibrahim Pharmaceuticals, and Glenmark.
Chapter 22 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provide a base for the information and statistics included in the report.
Chapter 23 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the nasal allergy treatment market.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Key Innovation / Development Trends
4. Key Success Factors
4.1. Promotional Strategies, By Key Manufacturers
4.2. Key Regulations
4.3. Reimbursement Scenario
4.4. Pipeline Analysis
4.5. Value Chain Analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Allergy Treatment Market Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Prevalence of Respiratory Disorders
5.2.2. Environmental Pollution
5.2.3. Growing Funding for R&D
5.2.4. Vast Product Pipeline
5.2.5. Rising Consumption of Tobacco
5.2.6. Availability of Alternate Treatments
5.2.7. New Product Launch Activities
5.2.8. Regulatory Approvals
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Treatment
6.1.2. By Disease
6.1.3. By Route of Administration
6.1.4. By Distribution Channel
6.1.5. By Country
6.2. 2021 Market Scenario
7. Global Nasal Allergy Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022–2032, By Treatment
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2017 – 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment, 2022 – 2032
8.3.1. Immunotherapy
8.3.2. Antihistamines
8.3.3. Decongestants
8.3.4. Corticosteroids
8.3.5. Others
8.4. Market Attractiveness Analysis By Treatment
9. Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022–2032, By Disease
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Disease , 2017 – 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2022 – 2032
9.3.1. Seasonal Allergic Rhinitis
9.3.2. Perennial Allergic Rhinitis
9.3.3. Occupational Allergic Rhinitis
9.4. Market Attractiveness Analysis By Disease
10. Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022–2032, By Route of Administration
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2017 – 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 – 2032
10.3.1. Oral
10.3.2. Nasal
10.3.3. Intraocular
10.3.4. Intravenous
10.4. Market Attractiveness Analysis By Route of Administration
11. Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022–2032, By Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2017 – 2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 – 2032
11.3.1. Retail Pharmacies
11.3.2. Hospital Pharmacies
11.3.3. E – Commerce
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Nasal Allergy Treatment Market Analysis 2017-2021 and Forecast 2022–2032, By Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa
12.4. Market Attractiveness Analysis By Region
13. North America Nasal Allergy Treatment Market Analysis 2017–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Treatment
13.3.3. By Disease
13.3.4. By Route of Administration
13.3.5. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Treatment
13.4.3. By Disease
13.4.4. By Route of Administration
13.4.5. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants – Intensity Mapping
13.7. Drivers and Restraints – Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. U.S. Nasal Allergy Treatment Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast By Market Taxonomy
13.8.1.2.1. By Country
13.8.1.2.2. By Treatment
13.8.1.2.3. By Disease
13.8.1.2.4. By Route of Administration
13.8.1.2.5. By Distribution Channel
13.8.2. Canada Nasal Allergy Treatment Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast By Market Taxonomy
13.8.2.2.1. By Country
13.8.2.2.2. By Treatment
13.8.2.2.3. By Disease
13.8.2.2.4. By Route of Administration
13.8.2.2.5. By Distribution Channel
14. Latin America Nasal Allergy Treatment Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. Mexico
14.3.1.2. Brazil
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.1.4.1. By Country
14.3.1.4.2. By Treatment
14.3.1.4.3. By Disease
14.3.1.4.4. By Route of Administration
14.3.1.4.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Treatment
14.4.3. By Disease
14.4.4. By Route of Administration
14.4.5. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints – Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Mexico Nasal Allergy Treatment Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast By Market Taxonomy
14.8.1.2.1. By Treatment
14.8.1.2.2. By Disease
14.8.1.2.3. By Route of Administration
14.8.1.2.4. By Distribution Channel
14.8.2. Brazil Nasal Allergy Treatment Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast By Market Taxonomy
14.8.2.2.1. By Country
14.8.2.2.2. By Treatment
14.8.2.2.3. By Disease
14.8.2.2.4. By Route of Administration
14.8.2.2.5. By Distribution Channel
14.8.3. Argentina Nasal Allergy Treatment Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast By Market Taxonomy
14.8.3.2.1. By Treatment
14.8.3.2.2. By Disease
14.8.3.2.3. By Route of Administration
14.8.3.2.4. By Distribution Channel
15. Europe Nasal Allergy Treatment Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Treatment
15.3.3. By Disease
15.3.4. By Route of Administration
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Treatment
15.4.3. By Disease
15.4.4. By Route of Administration
15.4.5. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints – Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Germany Nasal Allergy Treatment Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast By Market Taxonomy
15.8.1.2.1. By Treatment
15.8.1.2.2. By Disease
15.8.1.2.3. By Route of Administration
15.8.1.2.4. By Distribution Channel
15.8.2. Italy Nasal Allergy Treatment Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast By Market Taxonomy
15.8.2.2.1. By Treatment
15.8.2.2.2. By Disease
15.8.2.2.3. By Route of Administration
15.8.2.2.4. By Distribution Channel
15.8.3. France Nasal Allergy Treatment Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast By Market Taxonomy
15.8.3.2.1. By Treatment
15.8.3.2.2. By Disease
15.8.3.2.3. By Route of Administration
15.8.3.2.4. By Distribution Channel
15.8.4. U.K. Nasal Allergy Treatment Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast By Market Taxonomy
15.8.4.2.1. By Treatment
15.8.4.2.2. By Disease
15.8.4.2.3. By Route of Administration
15.8.4.2.4. By Distribution Channel
15.8.5. Spain Nasal Allergy Treatment Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast By Market Taxonomy
15.8.5.2.1. By Treatment
15.8.5.2.2. By Disease
15.8.5.2.3. By Route of Administration
15.8.5.2.4. By Distribution Channel
15.8.6. BENELUX Nasal Allergy Treatment Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast By Market Taxonomy
15.8.6.2.1. By Treatment
15.8.6.2.2. By Disease
15.8.6.2.3. By Route of Administration
15.8.6.2.4. By Distribution Channel
15.8.7. Russia Nasal Allergy Treatment Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast By Market Taxonomy
15.8.7.2.1. By Treatment
15.8.7.2.2. By Disease
15.8.7.2.3. By Route of Administration
15.8.7.2.4. By Distribution Channel
16. East Asia Nasal Allergy Treatment Market Analysis 2017–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Treatment
16.3.3. By Disease
16.3.4. By Route of Administration
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Treatment
16.4.3. By Disease
16.4.4. By Route of Administration
16.4.5. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints – Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. China Nasal Allergy Treatment Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast By Market Taxonomy
16.8.1.2.1. By Treatment
16.8.1.2.2. By Disease
16.8.1.2.3. By Route of Administration
16.8.1.2.4. By Distribution Channel
16.8.2. Japan Nasal Allergy Treatment Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast By Market Taxonomy
16.8.2.2.1. By Treatment
16.8.2.2.2. By Disease
16.8.2.2.3. By Route of Administration
16.8.2.2.4. By Distribution Channel
16.8.3. South Korea Nasal Allergy Treatment Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast By Market Taxonomy
16.8.3.2.1. By Treatment
16.8.3.2.2. By Disease
16.8.3.2.3. By Route of Administration
16.8.3.2.4. By Distribution Channel
17. South Asia Nasal Allergy Treatment Market Analysis 2017–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Treatment
17.3.3. By Disease
17.3.4. By Route of Administration
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Treatment
17.4.3. By Disease
17.4.4. By Route of Administration
17.4.5. By Distribution Channel
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints – Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. India Nasal Allergy Treatment Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast By Market Taxonomy
17.8.1.2.1. By Treatment
17.8.1.2.2. By Disease
17.8.1.2.3. By Route of Administration
17.8.1.2.4. By Distribution Channel
17.8.2. Indonesia Nasal Allergy Treatment Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast By Market Taxonomy
17.8.2.2.1. By Treatment
17.8.2.2.2. By Disease
17.8.2.2.3. By Route of Administration
17.8.2.2.4. By Distribution Channel
17.8.3. Malaysia Nasal Allergy Treatment Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast By Market Taxonomy
17.8.3.2.1. By Treatment
17.8.3.2.2. By Disease
17.8.3.2.3. By Route of Administration
17.8.3.2.4. By Distribution Channel
17.8.4. Thailand Nasal Allergy Treatment Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast By Market Taxonomy
17.8.4.2.1. By Treatment
17.8.4.2.2. By Disease
17.8.4.2.3. By Route of Administration
17.8.4.2.4. By Distribution Channel
18. Oceania Nasal Allergy Treatment Market 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Treatment
18.3.3. By Disease
18.3.4. By Route of Administration
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Treatment
18.4.3. By Disease
18.4.4. By Route of Administration
18.4.5. By Distribution Channel
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. Australia Nasal Allergy Treatment Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast By Market Taxonomy
18.7.1.2.1. By Treatment
18.7.1.2.2. By Disease
18.7.1.2.3. By Route of Administration
18.7.1.2.4. By Distribution Channel
18.7.2. New Zealand Nasal Allergy Treatment Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast By Market Taxonomy
18.7.2.2.1. By Treatment
18.7.2.2.2. By Disease
18.7.2.2.3. By Route of Administration
18.7.2.2.4. By Distribution Channel
19. Middle East and Africa (MEA) Nasal Allergy Treatment Market Analysis 2017–2021 and Forecast 2022–2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
19.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. North Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Treatment
19.3.3. By Disease
19.3.4. By Route of Administration
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Treatment
19.4.3. By Disease
19.4.4. By Route of Administration
19.4.5. By Distribution Channel
19.5. Market Trends
19.6. Key Market Participants – Intensity Mapping
19.7. Drivers and Restraints – Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Nasal Allergy Treatment Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast By Market Taxonomy
19.8.1.2.1. By Treatment
19.8.1.2.2. By Disease
19.8.1.2.3. By Route of Administration
19.8.1.2.4. By Distribution Channel
19.8.2. Turkey Nasal Allergy Treatment Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast By Market Taxonomy
19.8.2.2.1. By Treatment
19.8.2.2.2. By Disease
19.8.2.2.3. By Route of Administration
19.8.2.2.4. By Distribution Channel
19.8.3. South Africa Nasal Allergy Treatment Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast By Market Taxonomy
19.8.3.2.1. By Treatment
19.8.3.2.2. By Disease
19.8.3.2.3. By Route of Administration
19.8.3.2.4. By Distribution Channel
19.8.4. North Africa Nasal Allergy Treatment Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast By Market Taxonomy
19.8.4.2.1. By Treatment
19.8.4.2.2. By Disease
19.8.4.2.3. By Route of Administration
19.8.4.2.4. By Distribution Channel
20. Market Structure Analysis
20.1. Market Analysis By Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Merck & Co.
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Key Financials
21.3.1.5. SWOT Analysis
21.3.1.6. Strategic Overview
21.3.2. Boehringer Ingelheim
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Key Financials
21.3.2.5. SWOT Analysis
21.3.2.6. Strategic Overview
21.3.3. AstraZeneca
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Key Financials
21.3.3.5. SWOT Analysis
21.3.3.6. Strategic Overview
21.3.4. GlaxoSmithKline PLC
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Key Financials
21.3.4.5. SWOT Analysis
21.3.4.6. Strategic Overview
21.3.5. Sanofi S.A.
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Key Financials
21.3.5.5. SWOT Analysis
21.3.5.6. Strategic Overview
21.3.6. Johnson & Johnson
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Key Financials
21.3.6.5. SWOT Analysis
21.3.6.6. Strategic Overview
21.3.7. Teva Pharmaceutical Industries Ltd.
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Key Financials
21.3.7.5. SWOT Analysis
21.3.7.6. Strategic Overview
21.3.8. Alcon (Novartis AG)
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Key Financials
21.3.8.5. SWOT Analysis
21.3.8.6. Strategic Overview
21.3.9. Stallergenes Greer
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Key Financials
21.3.9.5. SWOT Analysis
21.3.9.6. Strategic Overview
21.3.10. Allergy Therapeutics
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Key Financials
21.3.10.5. SWOT Analysis
21.3.10.6. Strategic Overview
21.3.11. ALK-Abelló A/S
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Sales Footprint
21.3.11.4. Key Financials
21.3.11.5. SWOT Analysis
21.3.11.6. Strategic Overview
21.3.12. Hanmi Pharmaceutical
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Sales Footprint
21.3.12.4. Key Financials
21.3.12.5. SWOT Analysis
21.3.12.6. Strategic Overview
21.3.13. Immunotek
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Sales Footprint
21.3.13.4. Key Financials
21.3.13.5. SWOT Analysis
21.3.13.6. Strategic Overview
21.3.14. Regeneron Pharmaceuticals
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Sales Footprint
21.3.14.4. Key Financials
21.3.14.5. SWOT Analysis
21.3.14.6. Strategic Overview
21.3.15. Abdi Ibrahim Pharmaceuticals
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Sales Footprint
21.3.15.4. Key Financials
21.3.15.5. SWOT Analysis
21.3.15.6. Strategic Overview
21.3.16. Glenmark
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Sales Footprint
21.3.16.4. Key Financials
21.3.16.5. SWOT Analysis
21.3.16.6. Strategic Overview
22. Assumptions and Acronyms Used
23. Research Methodology